(Q43658280)
Statements
1 reference
Protocol #0207-545: a phase I/II, escalating dose, open-label evaluation of safety, feasibility, and tolerability of transgenic lymphocyte immunization (TLI) vaccine subjects with histologically proven prostate adenocarcinoma (English)
1 reference
Mauricio Zanetti
1 reference
1 February 2003
1 reference
1 reference
14
1 reference
3
1 reference
301-302
1 reference
Identifiers
1 reference